Oxford/AstraZeneca Vaccine has been approved for use in the UK, according to British media outlets.
The vaccine, codenamed AZD1222, was developed at the University of Oxford with support from British-Swedish pharmaceutical giant AstraZeneca.
The results of clinical trials showed that it is up to 90% effective in preventing coronavirus, which is almost identical to the protection provided by Pfizer / BioNTech and its competitor Moderna.
The UK has ordered 100 million doses from the manufacturer AstraZeneca, enough to vaccinate 50 million people.
It is the second vaccine to be approved in the UK after the Pfizer-BioNTech was given approval in December.
More than 600,000 people in the UK have been vaccinated since Margaret Keenan became the first in the world to get that jab outside of a clinical trial, according to BBC.
Follow the latest news on Google News
